Conference News Conference News Daily digests from key neurology conferences, written by on-site medical journalists. Published: Mar 10, 2020

Satralizumab safety and efficacy demonstrated in NMOSD

A new analysis of data from two Phase 3 clinical trials has demonstrated the safety and efficacy of satralizumab in the treatment of neuromyelitis optica spectrum disorder (NMOSD).